The cytoplasmic phase of hepadnavirus replication occurs in nucleocapsids and has been characterized in great detail (16, 19, 26) . The nuclear phase of hepadnavirus replication, on the other hand, is very poorly understood. Results of in vitro infection studies suggest that, after duck hepatitis B virus (DHBV) infects hepatocytes, the open circular (OC) virion DNA is released in the nucleus and is converted to covalently closed circular (CCC) DNA. Subsequently, the CCC DNA molecules serve as templates for production of viral mRNAs and pregenomic RNA (8, 12, 24) . The levels of CCC DNA in the nucleus have been shown to correlate with the levels of viral gene expression and replication (9, 20) .
Although OC DHBV DNA is the predominant molecule in DHBV virions, a minor fraction of virions contain doublestranded linear (DSL) molecules which are produced when viral plus-strand replication proceeds without translocation of the RNA primer ( Fig. 1A and B) . This process has been termed ''in situ'' priming (18) . The proportion of virions containing DSL molecules can be varied by introducing mutations which interfere with primer translocation. Thus, when translocation of the plus-strand primer is completely blocked, only virions containing DSL DNAs are produced (13) . Until recently, the fate of DSL DNAs in the nucleus was unknown. However, Yang and Summers have now shown that DSL molecules can be converted to CCC DNA molecules in the nucleus (29) .
The conversion of OC or DSL virion DNAs to CCC DNA molecules requires several enzymatically catalyzed reactions including removal of the terminal protein and the plus-strand RNA primer, resolution of the terminal redundancy in the minus strand, and filling in and ligation of the gaps and nicks in the plus and minus strands (Fig. 1A to C). These alterations are believed to require enzymatic reactions in the nucleus of the host cell. The balance between reactions which promote completion of CCC DNA molecules versus linearization of viral DNAs ultimately controls the level of productive replication, since molecules which remain in the DSL configuration cannot support viral replication (13, 29) .
In contrast to retroviruses, there is no requirement for hepadnaviruses to form proviruses in order to complete the replication cycle (16) . However, some proportion of viral DNA molecules which enter the nucleus are diverted into an integration pathway, since integrated viral DNAs have been cloned from chronically infected liver and hepatocellular carcinomas from chronic carriers (4, 5, 11, 14, 15, 17, 21, 22, 27, 28) . One of our goals has been to determine the mechanism of viral DNA integration in the nucleus in cells replicating wild-type hepadnaviruses. For these studies we have chosen an avian hepatoma cell line, LMH-D2, which efficiently replicates wildtype DHBV (3, 7) . In this report we characterize several DHBV integrations that originated from episomal DHBV DNAs.
Identification of DHBV integrations in LMH-D2 cells. Our initial approach was to use Southern blotting to characterize the major loci of integrated DHBV DNAs in LMH-D2 cells. The LMH-D2 cell line was derived from LMH chicken hepatoma cells that were stably transfected with a DHBV expression plasmid. The DHBV expression vector contains a greaterthan-unit-length DHBV DNA placed under the control of the cytomegalovirus (CMV) immediate-early promoter and the selectable marker neomycin resistance gene (neo) ( Fig. 2A ) (3) . These cells constitutively express DHBV RNAs, replicate DHBV DNA, and secrete mature infectious DHBV virions. Since LMH-D2 cells contain stable integrations of the transfected DHBV expression plasmid, we wanted to know whether integrated DHBV DNAs not linked to any plasmid vector sequences were present in the LMH-D2 nuclear DNA. Presumably, these integrations would be derived from episomal forms of DHBV in the LMH cells. We hybridized Southern blots of PvuII-digested nuclear DNA of LMH-D2 cells sequentially with probes homologous to DHBV, the Neo gene, or the CMV immediate-early promoter (Fig. 2) . PvuII cleaves the VOL. 69, 1995 NOTES 8103 DHBV expression plasmid once in the Neo gene and does not cleave the DHBV DNA (10) . As shown in Fig. 2B , nuclear DNA from LMH-D2 cells contained episomal forms of DHBV DNA designated OC, DSL, or CCC plus four high-molecularweight fragments containing integrated DHBV DNAs. The high-molecular-weight fragments Tr.1 and Tr.2 also hybridized to vector sequences (CMV and/or Neo), and we concluded that these bands were acquired during transfection. Fragments a and b were not linked to either the CMV sequence, the Neo sequence, or other plasmid sequences and were candidates for viral DNA integrations from episomal forms of DHBV.
Cloning and sequence analysis of the b integration in LMH-D2 cells. We designed an inverse PCR (23) strategy, utilizing oligonucleotide primers derived from the region of the DHBV genome flanking the cohesive overlap region to clone virus-cell junction fragments (Fig. 1D) . The strategy was designed to preferentially clone virus-cell DNA junctions in the vicinity of the direct repeat (DR) sequences, since they are known to be preferred integration sites for hepadnavirus DNA. In this protocol, we first digested the LMH-D2 nuclear DNA with either MboI or MspI, both of which cleave the DHBV genome several times but does not cleave the cohesive overlap region. The digested DNAs were then ligated in low concentrations to circularize individual fragments, and the desired junction fragments were linearized by XbaI digestion, whose site is located near the DR sequence, for viral integrations proceeding toward the core gene coding region or AvaI digestion for viral sequences proceeding toward the surface gene region ( Fig. 1A and D) . We then used nested primer pairs derived from regions of DHBV DNA on either side of the XbaI or AvaI site and inside the viral MspI or MboI site flanking the cohesive overlap as illustrated in Fig. 1D . With this strategy, we amplified two virus-cell junction DNA fragments from the MspI digest and one fragment from the MboI digest. These fragments were distinct from DNA fragments expected from episomal DHBV DNA or from the DHBV expression plasmid. After cloning and sequencing the fragments, we determined that one MspI fragment (Fig. 3A , fragment 2) contained a DHBV-cell junction at DHBV nt 2532 in the r region adjacent to DR1 and that the viral sequences proceeded toward the core gene region ( Fig. 3B and C, right junction). The other two fragments (Fig. 3A , fragments 1 and 3), one containing an MspI site and the other containing an MboI site, contained identical viral integration sites at DHBV nt 2537, with viral sequences proceeding toward DR2 ( Fig. 3B and C, left junction). The overlapping cellular sequences of the two fragments were also identical, suggesting that we had independently cloned the same junction fragment. DHBV nt 2537 is precisely at the 5Ј end of the DHBV minus strand, and the DHBV sequences in the junction fragment proceeded toward DR2 ( Fig. 3B and C, left junction).
Since the viral sequences in the two junction fragments proceeded into opposite regions of the DHBV genome, we predicted that the two junctions represented two ends of a single DHBV integration. To test this hypothesis, we synthesized oligonucleotide primers from the left and right cellular sequences and used them in a PCR with LMH-D2 DNA. We amplified a fragment slightly larger than 3 kb (fragment 8 in Fig. 3A) , and sequence analysis of the entire fragment confirmed that our hypothesis was correct ( Fig. 3A and B) . The integration contained an unrearranged, complete DHBV genome with a 6-bp DR at the ends of the DHBV integrant and with junctional sequences identical to the two junction fragments isolated previously (Fig. 3B) . Thus, we have isolated a complete DHBV integrant that contains a DHBV genome with a 6-bp terminal redundancy. The structure of the integrant suggests that it was a primary integration that was produced from either an OC virion DNA which was cleaved at staggered positions in the r region or a DSL virion DNA.
In order to isolate the fragments shown in Fig. 3A , for fragments 1 to 3, 9, and 10, which were isolated by inverse PCR, two noncontiguous segments of DNA (dashes) were coamplified through ligation of the MspI (Ms) ends (fragments 1 and 2), the MboI (Mb) ends (fragment 3), or BamHI (Ba) ends (fragments 9 and 10). The sequences of the oligonucleotide primers used for isolation of the fragments were as follows: fragment 1, DHBV nucleotides (nt) 1750 to 1731 and 2420 to 2439 followed by nested primers of nt 1710 to 1690 and 2441 to 2460; fragment 2, DHBV nt 2620 to 2600 and 2845 to 2864 followed by nt 2592 to 2573 and 2870 to 2890; fragment 3, DHBV nt 2252 to 2233 and 2420 to 2439 followed by primers of nt 2226 to 2207 and 2441 to 2460. Fragments 4 to 7 were amplified with one primer from the cellular sequences in junction fragment 1 (fragments 4 and 5) or 2 (fragments 6 and 7) and one primer deduced from the circular DHBV genome. The sequences of the primers were as follows: fragment 4, 5Ј-CGTGTCACCTTGCATCTCAACATC-3Ј (located in fragment 1) and DHBV nt 1812 to 1833; fragment 5, the same and DHBV nt 1440 to 1460, followed by 5Ј-AGATTGTTGC CACCGCTTGGT-3Ј and DHBV nt 1633to 1653. Analysis of the b integration chromosomal insertion site. In order to determine whether we had cloned integration a or b (Fig. 2) , we hybridized a Southern blot of LMH-D2 genomic DNA with flanking sequence probes immediately adjacent to the integrated DHBV DNA. Southern blot analysis indicated that both cellular junctional sequences immediately adjacent to the integration contained repetitive DNA elements (data not shown). We isolated a unique sequence probe from the integration site by first ''walking'' further away from the DHBV integration using a second inverse PCR protocol (see above). This protocol produced two fragments extending to the next BamHI site in the cellular DNA (fragments 9 and 10 in Fig. 3A) . The 1.5-kb PstI-BamHI fragment (Fig. 3A) in the right-hand flanking sequence contained unique cellular sequences and was used as a probe to identify the integration in LMH-D2 cells. We found that it hybridized to the PvuII fragment which we previously identified as integration b (data not shown). (Further analysis of the integration site in an LMH-D2 subclone which lost the b integration will be published separately.)
Analysis of the cellular flanking sequences of integration b revealed a 70-bp DR immediately adjacent to the ends of the viral integrant (Fig. 3B) . Segments of the repeated sequence are underlined by arrows in Fig. 3B , and the entire sequence is shaded in Fig. 3D . In order to determine whether this repeat occurred as a result of DHBV integration, we cloned the normal cellular sequence spanning the integration site. To do this, we used cellular DNA primers homologous to the left and right cellular flanking sequences and amplified a 320-bp fragment from the parental LMH cell line (see the legend to Fig. 3D ). Sequence analysis of several independent clones of the PCR product showed that they contained only a single copy of the 70-bp sequence (Fig. 3D) . Thus, we conclude that integration of the viral genome resulted in duplication of a 70-bp cellular sequence at the integration site. Interestingly, a 9-bp DR (Fig.  3D , boxed sequences) was also found at the ends of the 70-bp cellular DNA sequence.
Cloning of additional new viral-cell junction fragments from LMH-D2 cells. In order to determine whether the viral sites in the b integration might represent common integration sites for DHBV DNA in LMH-D2 cells, we searched for additional new integrations in subclones of the LMH-D2 cell line. We hypothesized that stable DHBV integrations that occurred in a subpopulation of LMH-D2 cells could be detected by analyzing the DNA from subclones grown from single cells. Single-cell suspensions of LMH-D2 cells were plated out at low cell density, and single colonies were picked and grown into subclones. Southern blot analysis of three generations of subclones generated in this manner demonstrated that new integrations do arise in LMH-D2 cells, and a lineage analysis of the subclones will be published separately (3a) . Southern blot analysis of one second-generation subclone, P1(21)-2, and one third-generation subclone, P1(21)-9-8, which identified three new integrations in LMH-D2 cells is shown in Fig. 4A .
We cloned DHBV-cell DNA junction fragments from these subclones, using the same inverse PCR strategy as earlier, and the sequence analysis of four virus-cell junctions is shown in Fig. 4B . One of the viral junctions was within the terminal redundancy of the minus strand at nt 2533, with the viral sequence proceeding toward the core gene. This viral junction was only 1 bp away from the corresponding junction in the b integration. Two additional viral junctions were located between DR1 and DR2, at nt 2503 and 2507, with DHBV sequences proceeding toward DR2 (Fig. 4B and C) . A fourth viral junction mapped within DR2, with the viral sequence proceeding toward the surface gene coding region (Fig. 4B and  C) . The DNA sequences of all of the new integrations were confirmed by rederiving them with a unique new cellular primer from each one plus a different DHBV primer and then cloning and sequencing (data not shown).
To unequivocally demonstrate that the virus-cell junctions represented new integrations, the pairs of viral and cellular primers used to amplify the fragments containing the new junctions were used in PCRs with the original LMH-D2 cell DNA and the first-, second-, and third-generation subclones. As shown in Fig. 5 , a 930-bp fragment containing the viral junction 1 shown in Fig. 4B was amplified from DNA of the second-generation subclone P1 (21)-2 (lane 2) and from DNAs of 12 third-generation single-cell subclones (lanes 3 to 14) derived from P1(21)-2. All 12 third-generation subclones contained the new integration detected in P1(21)-2 ( Fig. 4A) by Southern analysis (3a) . In contrast, the 930-bp fragment was not detected in the parental first-generation subclone P1(21) (Fig. 5, lane 1 Fig. 4B were not amplified from DNA of the parental second-generation subclone P1(21)-9 or the first-generation subclone P1(21) (data not shown). Thus, we detected new DHBV integrations arising in LMH-D2 subclones which contained unique virus-cell junctions. Therefore we conclude that the region of DHBV DNA between DR1 and DR2 serves as a substrate for integration and that the terminal redundancy r is a preferred integration sequence within this region. Proposed mechanism for the b integration. On the basis of our sequence analysis, we propose a three-step process by which the b integration may have occurred (Fig. 6) . The basic steps of the integration mechanism include (i) enzymatic modification of the DHBV integration substrate and cleavage of cellular DNA at staggered positions ( Fig. 6A and B) , (ii) integration of a linearized DHBV molecule (Fig. 6C) , and (iii) resolution of the ends of the newly integrated DHBV DNA (Fig. 6D) . The enzymatic modifications of DHBV DNA required in step 1 include removal of the terminal protein, cleavage of the minus strand at nt 2532, and removal of the plusstrand RNA primer. This would produce a modified DSL DHBV DNA molecule which would be capable of integrating into cellular DNA (Fig. 6B) . Sequence analysis reveals a 3-bp homology with cellular DNA on the right side and 1-bp homology with cellular DNA on the left side of the integration (Fig. 6C, asterisks) . The tandem duplication of the 70-bp cellular sequence suggests that the cellular DNA was nicked at staggered positions to provide the integration acceptor ( Fig.  6A and B) . Interestingly, the potential nick sites in cellular DNA occur within a 9-bp DR which flanks the 70-bp sequence. These sequences may have properties which make them more susceptible to cleavage by cellular enzymes. In our model, the 3Ј recessed ends (Fig. 6B ) in cellular DNA must be extended by cellular enzymes before the DHBV DNA integrates, because the cellular DNA must be filled in (Fig. 6B and C, dotted arrows) in order to provide the cellular DNA strand with 1-or 3-bp homology to the plus-and minus-strand ends of DHBV DNA, respectively. Finally, resolution of the sites at which viral and cellular DNA ends interact, utilizing nucleic acid enzymes in the nucleus, is required to complete the integration structure.
Additional characteristics of hepadnavirus integrations. Other DHBV DNAs such as OC or CCC molecules could also be modified to produce integration substrates similar to that in the b integration. Thus, a nick adjacent to nt 2532 on the plus strand of an OC DHBV DNA or staggered nicks near nt 2532 on a CCC DNA would likely linearize the DNA molecule, which could also be a potential integration substrate. However, the ends of such linearized OC or CCC molecules would be expected to have structures different from those of a DSL DNA and therefore would presumably require modifications different from those proposed in Fig. 6 in order to produce the substrate for b integration. The additional junction fragments we cloned illustrate that the specific DHBV nucleotides which become linked to cellular DNA vary within the cohesive overlap region and extend at least to DR2. These integrations may result from a scenario that an enzymatically modified DSL DHBV DNA molecule described in Fig. 6 is further subjected to DNase attacks prior to being engaged in integration reactions. It remains to be seen whether the simple, unrearranged hepadnavirus integrations containing less than a full genome originate from DSL viral DNAs.
The inverse PCR strategy used in this study could potentially detect virus-cell junctions located in a 1-kb region of DHBV DNA surrounding the DR1 and DR2 sequences (Fig. 1) . However, all the virus-cell junctions we cloned were located within the cohesive overlap between or within DR1 and DR2. A previous report of three DHBV integrations isolated from a duck hepatoma also revealed a strong preference for viral integration sites in the cohesive overlap region (6) . Thus, our (29) . Sequence analysis of the CCC DNA molecules across the joint between the 5Ј ends of the plus and minus strands revealed a high rate of illegitimate recombination which created mutant CCC DNAs. One of the most highly preferred mutant joints occurred between nt 2537, which is the 5Ј end of the minus strand, and the 9-nt r region at the 3Ј end of the minus strand. These positions are the same as the junctions of the b integration in this report. The data of Yang and Summers demonstrate that the ends of DSL DHBV molecules participate in illegitimate recombination in both inter-and intramolecular reactions. Our data suggest that appropriately modified DSL molecules also participate in illegitimate recombination with chromosomal DNA.
One remaining question is why the cohesive overlap region is apparently a preferred integration site. Assuming that integration must be mediated by cellular enzymes, structural features of this region of virion DNA which would confer selective sensitivity to a specific nucleic acid enzyme might be expected to enhance integration mediated by that enzyme. The nucleotide sequences across the r region of DHBV DNA have a strong resemblance to a hexadecameric sequence which is a high-efficiency topoisomerase I cleavage sequence (2) . In separate work, we have mapped topoisomerase I cleavage sites at either end of the DHBV r sequence (6a). Since the ends of the r region of the DHBV virion DNA have the structure of topoisomerase I suicide substrates, cleavage at these sites might be expected to lead to illegitimate recombination with cellular DNA (1). Previous work demonstrating that topoisomerase I can mediate integration of woodchuck hepatitis virus DNA in its corresponding r region (25) suggests that the mechanism may be common for hepadnaviruses.
